Fast Five Quiz: Systemic Treatments for Plaque Psoriasis

Chris G. Adigun, MD; William James, MD


December 21, 2021

Approximately 125 million people around the world have psoriasis, a chronic, relapsing inflammatory skin disorder. Several clinical variants of psoriasis are recognized, but plaque psoriasis is the most common. Psoriasis is associated with a significantly increased risk for numerous serious comorbidities, including psoriatic arthritis, depression, obesity, diabetes, liver disease, metabolic syndrome, and cardiovascular disease. Patients with moderate to severe psoriasis often receive either no treatment or treatment with topical agents only and report disappointment with therapy, poorly managed symptoms, and sustained effect of the disease on quality of life. A variety of systemic therapies are available and have been shown to be more effective than topical monotherapy in minimizing clinical symptoms, attaining treatment efficacy targets, and improving quality of life.

How much do you know about systemic treatments for plaque psoriasis? Test your knowledge with this quick quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.